OPKO Health, Inc.
OPKHealthcareNASDAQDiagnostics & Research
Scan Results
Daily timeframeOPKO Health, Inc. operates as a healthcare company, in the United States, Ireland, Chile, Spain, Israel, Mexico, and internationally. At a $1.22B market cap, OPKO Health, Inc. ranks as a small-cap company within healthcare. The company operates in two segments, Pharmaceutical and Diagnostics.
Market Cap
$1.22B
Beta
1.50
P/E (TTM)
—
P/E (Fwd)
-4.75
EPS (TTM)
$-0.09
EPS (Fwd)
$-0.34
ROE
-5.9%
ROA
-5.5%
Cash
$300.8M
Total Debt
$398.1M
Free CF
$54.8M
52W Change
12.4%
Annual Financials
Cash vs Debt
Where OPK stands vs its 150-day and 200-day moving averages
As of the October 20, 2026 close, OPK finished 18.38% above its 150-day moving average ($1.36) and 21.05% above its 200-day moving average ($1.33). This snapshot is end-of-day data shown with a five-trading-day delay on the free plan; Premium members see readings from the latest close.
Is OPK overbought or oversold?
At the October 20, 2026 close, OPK's RSI(14) was 49.4, in neutral territory (between 30 and 70). The MACD histogram was positive, so short-term momentum leaned bullish at that close. These readings are historical, refresh daily after market close, and are not investment advice.
The company holds $300.8M in cash, though total debt stands at $398.1M. This level of leverage is common in the industry but worth monitoring as interest rate conditions evolve. The company generates $54.8M in free cash flow annually, which funds everything from R&D to shareholder returns without needing external financing. ROE of -5.9% points to negative capital efficiency, indicating how much profit the company produces per dollar of shareholder equity. Revenue has pulled back from $1.00B (2022) to $606.9M (2025), a 40% decline worth watching.
A beta of 1.50 means OPK is more volatile than average. Investors should be prepared for wider price swings relative to broader indices. These risk factors are not exhaustive — macroeconomic shifts, regulatory changes, and competitive dynamics can all influence OPKO Health, Inc.'s trajectory.